Literature DB >> 16606917

Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome.

G Uyanik1, N Elcioglu, J Penzien, C Gross, Y Yilmaz, A Olmez, E Demir, D Wahl, K Scheglmann, B Winner, U Bogdahn, H Topaloglu, U Hehr, J Winkler.   

Abstract

BACKGROUND: Andermann syndrome (OMIM 218000) is an autosomal recessive motor-sensory neuropathy associated with developmental and neurodegenerative defects. The cerebral MRI reveals a variable degree of agenesis of the corpus callosum. Recently, truncating mutations of the KCC3 gene (also known as SLC12A6) have been associated with Andermann syndrome.
METHODS: The authors assessed clinically and genetically three isolated cases from Germany and Turkey with symptoms consistent with Andermann syndrome.
RESULTS: The authors detected four novel mutations within the KCC3 gene in their patients: two different truncating mutations in the first patient, a homozygous truncating mutation in the second, and a homozygous missense mutation in the third patient. In contrast to the classic phenotype of the Andermann syndrome linked to truncating KCC3 mutations the phenotype and the course of the disease linked to the missense mutation appeared to be different (i.e., showing additional features like diffuse and widespread white matter abnormalities).
CONCLUSIONS: Not only truncating but also missense mutations of the KCC3 gene are associated with Andermann syndrome. Different types of KCC3 mutations may determine different clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606917     DOI: 10.1212/01.wnl.0000204181.31175.8b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  Physiological roles and molecular mechanisms of K+ -Cl- cotransport in the mammalian kidney and cardiovascular system: where are we?

Authors:  A P Garneau; A A Marcoux; S Slimani; L E Tremblay; R Frenette-Cotton; F Mac-Way; P Isenring
Journal:  J Physiol       Date:  2019-02-09       Impact factor: 5.182

2.  Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosum.

Authors:  Jinlong Ding; Eric Delpire
Journal:  Behav Brain Res       Date:  2014-08-10       Impact factor: 3.332

3.  Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter.

Authors:  Kristopher T Kahle; Bianca Flores; Diana Bharucha-Goebel; Jinwei Zhang; Sandra Donkervoort; Madhuri Hegde; Gulnaz Hussain; Daniel Duran; Bo Liang; Dandan Sun; Carsten G Bönnemann; Eric Delpire
Journal:  Sci Signal       Date:  2016-08-02       Impact factor: 8.192

Review 4.  Mutations affecting GABAergic signaling in seizures and epilepsy.

Authors:  Aristea S Galanopoulou
Journal:  Pflugers Arch       Date:  2010-03-30       Impact factor: 3.657

Review 5.  K-Cl cotransporters, cell volume homeostasis, and neurological disease.

Authors:  Kristopher T Kahle; Arjun R Khanna; Seth L Alper; Norma C Adragna; Peter K Lauf; Dandan Sun; Eric Delpire
Journal:  Trends Mol Med       Date:  2015-07-01       Impact factor: 11.951

6.  Truncating SLC12A6 variants cause different clinical phenotypes in humans and dogs.

Authors:  Mario Van Poucke; Kimberley Stee; Laurien Sonck; Emmelie Stock; Leslie Bosseler; Jo Van Dorpe; Filip Van Nieuwerburgh; Dieter Deforce; Luc J Peelman; Luc Van Ham; Sofie F M Bhatti; Bart J G Broeckx
Journal:  Eur J Hum Genet       Date:  2019-06-03       Impact factor: 4.246

7.  KCC3 axonopathy: neuropathological features in the central and peripheral nervous system.

Authors:  Roland N Auer; Janet L Laganière; Yves O Robitaille; John Richardson; Patrick A Dion; Guy A Rouleau; Masoud Shekarabi
Journal:  Mod Pathol       Date:  2016-05-27       Impact factor: 7.842

8.  Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum.

Authors:  Adèle Salin-Cantegrel; Jean-Baptiste Rivière; Masoud Shekarabi; Sarah Rasheed; Sandra Dacal; Janet Laganière; Rébecca Gaudet; Daniel Rochefort; Gaëtan Lesca; Claudia Gaspar; Patrick A Dion; Jean-Yves Lapointe; Guy A Rouleau
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

Review 9.  Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts.

Authors:  Kenneth B Gagnon; Eric Delpire
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

10.  A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.

Authors:  Yan Jiao; Xiudong Jin; Jian Yan; Chi Zhang; Feng Jiao; Xinmin Li; Bruce A Roe; David B Mount; Weikuan Gu
Journal:  Genomics       Date:  2008-03-14       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.